Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2022 > Vol 3, №5 (2022) > COVID-associated neuro-ophthalmopathy. Issues of diagnosis and treatment

COVID-associated neuro-ophthalmopathy. Issues of diagnosis and treatment

Igor N. Stepanov , Elena V. Savchenko , Marina R. Kovaleva , Nikita Yu. Shalkin

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Since the beginning of the COVID-19 pandemic, a large number of reports on extrapulmonary manifestations of the disease have appeared, sometimes focusing on complex cases and challenging diagnostic tasks. Neuroophthalmological manifestations of COVID-19 include opticoneuritis, acute transverse myelitis, viral encephalitis, toxic encephalopathy, leukoencephalopathy, acute disseminated encephalomyelitis and some other conditions. 30.8% of patients with neurological symptoms of COVID-19 have idiopathic intracranial hypertension. The breadth of the diagnostic search complicates the task of the doctor to choose right diagnostic measures and treatment tactics. This article presents the clinical observation of a patient with ophthalmopathy and idiopathic intracranial hypertension during the post-COVID period. The case deserves special attention in the context of differential diagnosis with autoimmune diseases. We also present current publications on the topic of ophthalmopathy of various etiologies, including a new coronavirus infection, focusing on its role in the development of ocular and neurological symptoms. The current epidemiological situation implies the mandatory consideration of infectious pathology during diagnostics search. Understanding the impact of COVID-19 on human organs and systems and timely diagnosis will help to reduce the time spent on ineffective treatment and expensive diagnostic measures.
Key words: optical neuropathy, idiopathic intracranial hypertension, COVID-19.

About the Author

Igor N. Stepanov 1 , Elena V. Savchenko 1 , Marina R. Kovaleva 1 , Nikita Yu. Shalkin 2

1 Omsk State Medical University, Omsk, Russia

2 Omsk Regional Clinical Hospital, Omsk, Russia

References

1. Ling XC, Kang EY, Lin JY et al. Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis. Taiwan J Ophthalmol 2020; 10 (3): 153–66. DOI: 10.4103/tjo.tjo_53_20!21
2. Finsterer J, Scorza FA, Scorza CA et al. Vascular Damage May Mimic Retinitis and Optic Neuritis in COVID-19. Curr Eye Res 2021; 46 (12): 1934–5. DOI: 10.1080/02713683.2021.1896743 
3. Jossy A, Jacob N, Sarkar S et al. COVID-19-associated optic neuritis – A case series and review of literature. Indian J Ophthalmol 2022; 70 (1): 310–6. DOI: 10.4103/ijo.IJO_2235_21
4. Azab MA, Hasaneen SF, Hanifa H et al. Optic neuritis post-COVID-19 infection. A case report with meta-analysis. Interdisciplin Neurosurg 2021; 26: 101320. DOI: 10.1016/j.inat.2021.101320
5. Espíndola OM, Brandão CO, Gomes YCP et al. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int J Infect Dis 2021; 102: 155–62. DOI: 10.1016/j.ijid.2020.10.044
6. Medicherla CB, Pauley RA, Havenon A et al. Cerebral venous sinus thrombosis in the COVID-19 pandemic. J Neuroophthalmol 2020; 8: 741594. DOI: 10.3389/fmed.2021.741594
7. Petzold A, Fraser CL, Abegg M et al. Diagnosis and classification of optic neuritis. Lancet Neurology 2022; 21 (12): 1120–34. DOI: 10.1016/S1474-4422(22)00200-9
8. Cross SA. Rethinking Neuromyelitis Optica (Devic Disease). J Neuro-Ophthalmol 2007; 27 (1): 57–60. DOI: 10.1097/WNO. 0b013e3180334d27
9. Калашникова А.К., Шеремет Н.Л., Андреева Н.А. и др. Оптикомиелит, ассоциированный с наличием антител к гликопротеину миелиновых олигодендроцитов. Клинический случай. Consilium Medicum. 2022; 24 (2): 132–6. DOI: 10.26442/20751753. 2022.2.201391
[Kalashnikova A.K., Sheremet N.L., Andreeva N.A. et al. Optikomielit, associirovannyj s nalichiem antitel k glikoproteinu mielinovyh oligodendrocitov. Klinicheskij sluchaj. Consilium Medicum. 2022; 24 (2): 132–6. DOI: 10.26442/20751753.2022.2.201391 (in Russian).]
10. Jarius S, Paul F, Aktas O et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15 (1): 134. DOI: 10.1186/s12974-018-1144-2
11. Елисеева Д.Д., Васильев А.В., Шабалина А.А. и др. Энцефаломиелиты, ассоциированные с антителами к миелинолигодендроцитарному гликопротеину. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020; 120 (7–2): 13–23. DOI: 10.26442/20751753. 2022.2.201391
[Eliseeva D.D., Vasil'ev A.V., Shabalina A.A. et al. Jencefalomielity, associirovannye s antitelami k mielinoligodendrocitarnomu glikoproteinu. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2020; 120 (7–2): 13–23. DOI: 10.26442/20751753.2022.2.201391 (in Russian).]
12. Sen M, Honavar SG, Sharma N et al. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol 2021; 69 (3): 488–509. DOI: 10.4103/ijo.IJO_297_21
13. Bayazit I, Cokal BG, Mungan Y. Intracranial hypertension and visual loss following COVID-19: A case report. Indian J Ophthalmol 2021; 69 (6): 1625–7. DOI: 10.4103/ijo.IJO_342_21
14. Лобан Д.С., Ильина Д.В. Ишемическая оптическая нейропатия на фоне заболевания COVID-19. Проблемы и перспективы развития современной медицины. 2021; 6: 137–40. Режим доступа: http://elib.gsmu.by/handle/GomSMU/8672
[Loban D.S., Il'ina D.V. Ishemicheskaja opticheskaja nejropatija na fone zabolevanija COVID-19. Problemy i perspektivy razvitija sovremennoj mediciny. 2021; 6: 137–40. Rezhim dostupa: http://elib. gsmu.by/handle/GomSMU/8672 (in Russian).]
15. Silva MTT, Lima MA, Torezani G et al. Isolated intracranial hypertension associated with COVID-19. Cephalalgia 2020; 40 (13): 1452–8. DOI: 10.1177/0333102420965963
16. Sardar S, Safan A, Okar L et al. The diagnostic dilemma of bilateral optic neuritis and idiopathic intracranial hypertension coexistence in a patient with recent COVID-19 infection. Clin Case Rep 2021; 9: 43–7. DOI: 10.1002/ccr3.4347
17. Jin YP, Trope GE, El-Defrawy S et al. Ophthalmology-focused publications and findings on COVID-19: A systematic review. Eur J Ophthalmol 2021; 31 (4): 1677–87. DOI: 10.1177/1120672121992949
18. Ung L, Chodosh J. COVID-19 and the eye: alternative facts The 2022 Bowman Club, David L. Easty lecture. BMJ Open Ophthalmol 2022; 
7 (1): 10–42. DOI: 10.1136/bmjophth-2022-001042
19. Lewis A, Frontera J, Placantonakis DG et al. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci 2021; 421: 117316. DOI: 10.1016/j.jns.2021.117316
20. Chen Q, Allot A, Lu Z. Keep up with the latest coronavirus research. Nature 2020; 579 (7798): 193. DOI: 10.1038/d41586-020-00694-1


For citation:Stepanov I.N., Savchenko E.V., Kovaleva M.R., Shalkin N.Yu. COVID-associated neuro-ophthalmopathy. Issues of diagnosis and treatment. Clinical analysis in general medicine. 2022; 5: 51–55. DOI: 10.47407/kr2022.3.5.00162


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru